For HCPs Only
Recent Clinical Updates
Loading latest clinical updates

Clinical Intelligence & Drug Records for US-Licensed Practitioners

The integrated, institutional-grade registry trusted by US-licensed practitioners for evidence-based clinical data, drug information, and peer-reviewed drug updates.

Drug Update Briefing

Weekly drug approvals, safety updates, and specialty coverage for healthcare professionals.

Clinical Resources

Drug updates, reference data, and specialist-led coverage.

Recent Clinical Updates

Latest Drug & Specialty Updates

View All

Specialty Coverage

Therapeutic-area updates for clinical review.

All Specialties

Drug Information

FDA drug records and prescribing context.

Review drug records, NDC references, dosage tools, and interaction resources alongside clinical coverage.

FDA data

Drug Reference

Drug approvals, labels, and clinical context.

Access structured FDA label data, dosage references, NDC records, interactions, and prescribing context.

Clinical Coverage

Additional Drug Updates

Pulmonology

FDA Approves Dupilumab for COPD: 30% Exacerbation Reduction in BOREAS Trial

2h ago|3 min read|By Dr. Nikhil Chatterjee
Neurology

FDA Approves Donanemab for Alzheimer’s Disease: Amyloid Plaque Reduction in TRAILBLAZER-ALZ 2 Trial

2h ago|3 min read|By Dr. Vikram Patel
Pulmonology

FDA Approves Tezepelumab for Severe Asthma: 52% Exacerbation Reduction in NAVIGATOR Trial

2h ago|3 min read|By Dr. Nikhil Chatterjee
Hematology

FDA Approves Imetelstat for MDS: 39.8% RBC Transfusion Independence

2h ago|3 min read|By Dr. Shruti Pandey
Endocrinology

Orforglipron vs Semaglutide: Efficacy Comparison in Weight Loss Without Food Restrictions

2h ago|3 min read|By Dr. Amit Desai
Cardiology

FDA Approves Semaglutide for HFpEF: 52% Improvement in Heart Failure Symptoms

2h ago|3 min read|By Dr. Arjun Sharma
Cardiology

FDA Approves Semaglutide for Peripheral Artery Disease: STRIDE Trial Shows Improved Walking Distance

2h ago|3 min read|By Dr. Arjun Sharma
Otolaryngology

FDA Approves Lunsotogene Parvec for Genetic Hearing Loss: First-Ever Gene Therapy

May 5|3 min read|By Editorial Team
Dermatology

FDA Approves Dupilumab for Atopic Dermatitis: Key Comparisons with Tralokinumab, Lebrikizumab, and Difamilast

May 5|3 min read|By Dr. Rohan Gupta
Rare Disease

FDA Approves Tividenofusp Alfa for Hunter Syndrome: First Enzyme Replacement Therapy for Neurologic Symptoms

May 5|3 min read|By Editorial Team
Cardiology

PCSK9 Inhibitors: Evolocumab, Alirocumab, and Inclisiran Reduce LDL-C by 50% in 2024 Guidelines

May 5|3 min read|By Dr. Kavya Sharma
Oncology

FDA Approves Mirdametinib for Neurofibromatosis Type 1: 52% ORR in Pediatric Patients

May 5|3 min read|By Dr. Meera Pillai
Hematology

FDA Approves Bitopertin for Erythropoietic Protoporphyria: A New Treatment Option

May 5|3 min read|By Dr. Shruti Pandey
Infectious Disease

FDA Approves Idvynso for HIV-1 Treatment: New Combination Therapy for Adults

May 5|3 min read|By Dr. Simran Kohli
Cardiology

FDA Approves Enlicitide for LDL Cholesterol Reduction: 30% Decrease in Phase 3 Trial

May 5|3 min read|By Dr. Arjun Sharma
Oncology

FDA Approves LYNOZYFIC for Multiple Myeloma: 80% Response Rate in Relapsed Patients

May 5|3 min read|By Dr. Meera Pillai
Otolaryngology

FDA Approves Dupilumab for Allergic Fungal Rhinosinusitis: First Treatment Option for Patients

May 4|3 min read|By Editorial Team
Endocrinology

FDA Approves Foundayo for Obesity: New GLP-1 Pill Option

May 4|3 min read|By Dr. Amit Desai
Infectious Disease

FDA Reviews Ensitrelvir for COVID-19 Post-Exposure Prevention: First Oral Antiviral in 2026

May 4|3 min read|By Dr. Simran Kohli
Endocrinology

FDA Approves Afrezza for Pediatric Use: First Inhaled Insulin for Type 1 and Type 2 Diabetes in Children

May 4|3 min read|By Dr. Amit Desai
Neurology

FDA Approves Wellcovorin for Cerebral Folate Transport Deficiency: First Treatment Available

May 4|3 min read|By Dr. Vikram Patel
Dermatology

Difamilast vs Crisaborole: Topical PDE4 Inhibitors for Atopic Dermatitis in Pediatrics and Adults

May 4|3 min read|By Dr. Divya Agarwal
Pulmonology

FDA Approves Depemokimab for Severe Asthma: New Eosinophilic Treatment Option

May 3|3 min read|By Dr. Nikhil Chatterjee